NCT03130179View on ClinicalTrials.gov

A Bioequivalence Study Between Two Nicotine Replacement Therapies in Adult Healthy Smokers Motivated to Quit.

PHASE1CompletedINTERVENTIONAL
Enrollment

244

Participants

Timeline

Start Date

March 20, 2017

Primary Completion Date

June 19, 2017

Study Completion Date

June 29, 2017

Conditions
Tobacco Dependence
Interventions
DRUG

Nicorette Strongmint lozenge 4 mg

A single dose of one Nicorette lozenge 4mg lozenge administrated orally to slowly dissolve in the mouth.

DRUG

Niquitin MiniMint lozenge 4 mg

A single dose of one Niquitin Minimint lozenge 4mg administrated orally to slowly dissolve in the mouth.

Trial Locations (1)

Unknown

"Scientific and Clinical Center of JSC RZD", Moscow

Sponsors

Lead Sponsor

McNeil AB
All Listed Sponsors
lead

McNeil AB

INDUSTRY